PRESS RELEASE published on 07/11/2024 at 14:00, 2 years 3 months ago Rentschler Biopharma Announces New State-of-the-Art Production Line in Massachusetts is Fully Operational Rentschler Biopharma SE announces full operational status of new state-of-the-art production line in Massachusetts, marking largest expansion in company's history Expansion Manufacturing Biopharmaceuticals Rentschler Biopharma SE State-of-the-art Production Line
BRIEF published on 05/28/2024 at 13:05, 2 years 5 months ago Rentschler Biopharma Appoints Patrick Meyer as Global Head BD Sales and Alliance Management Business Development Rentschler Biopharma Biopharmaceuticals Patrick Meyer
BRIEF published on 05/28/2024 at 13:05, 2 years 5 months ago Rentschler Biopharma nomme Patrick Meyer au poste de responsable mondial des ventes et de la gestion des alliances BD Rentschler Biopharma Produits Biopharmaceutiques Développement Des Affaires Patrick Meyer
PRESS RELEASE published on 05/28/2024 at 13:00, 2 years 5 months ago Rentschler Biopharma Appoints Patrick Meyer as Global Head BD Sales and Alliance Management Rentschler Biopharma appoints Patrick Meyer as Global Head BD Sales and Alliance Management, demonstrating commitment to client centricity and global business development Business Development Rentschler Biopharma Biopharmaceuticals Patrick Meyer Alliance Management
BRIEF published on 05/02/2024 at 14:15, 2 years 6 months ago Rentschler Biopharma promeut Patrick Cushing au poste de vice-président des opérations pour sa filiale américaine Rentschler Biopharma Expansion De La Fabrication Produits Biopharmaceutiques Gestion Opérationnelle Patrick Cushing
BRIEF published on 05/02/2024 at 14:15, 2 years 6 months ago Rentschler Biopharma Promotes Patrick Cushing as VP Operations for U.S. Subsidiary Operational Management Rentschler Biopharma Biopharmaceuticals Manufacturing Expansion Patrick Cushing
PRESS RELEASE published on 05/02/2024 at 14:10, 2 years 6 months ago Rentschler Biopharma Appoints Patrick Cushing as VP Operations for U.S. Subsidiary Rentschler Biopharma appoints Patrick Cushing as VP Operations for U.S. subsidiary, showcasing commitment to delivering high-quality services and expanding production capacity Expansion Rentschler Biopharma Biopharmaceutical Manufacturing Patrick Cushing VP Operations
BRIEF published on 03/06/2024 at 10:05, 2 years 8 months ago Rentschler Biopharma SE joue un rôle important dans les produits biopharmaceutiques approuvés par la FDA en 2023 Rentschler Biopharma Produits Biopharmaceutiques Innovation En Matière De Soins De Santé Approbation De La FDA Développement Biotechnologique
BRIEF published on 03/06/2024 at 10:05, 2 years 8 months ago Rentschler Biopharma SE Plays Significant Role in 2023 FDA Approved Biopharmaceuticals FDA Approval Healthcare Innovation Rentschler Biopharma Biopharmaceuticals Biotech Development
PRESS RELEASE published on 03/06/2024 at 10:00, 2 years 8 months ago Rentschler Biopharma contributes to nearly 25% of FDA approved biopharmaceuticals in 2023 Rentschler Biopharma contributed to nearly 25% of FDA approved biopharmaceuticals in 2023, showcasing its expertise in bioprocess development and manufacturing CDMO FDA Approval Rentschler Biopharma Biopharmaceuticals Therapeutics
Published on 11/10/2026 at 21:00, 31 minutes ago Golden Minerals Announces Completion of Offering for C$5,000,000
Published on 11/10/2026 at 14:45, 6 hours 46 minutes ago An Investigational Drug to Tackle Measles Outbreaks
Published on 11/10/2026 at 14:31, 7 hours ago First Breach Plans to Integrate Onboard AI Computing into CQS and LRS Drone Platforms
Published on 11/10/2026 at 14:30, 7 hours 1 minute ago Stabilis Solutions Announces Three-Year Take-Or-Pay LNG Supply Agreement with Existing Aerospace Customer
Published on 11/10/2026 at 14:30, 7 hours 1 minute ago ACCESS Newswire Reports Third Quarter 2026 Results
Published on 11/10/2026 at 19:21, 2 hours 10 minutes ago ALTHEORA, Mäder Composites France et IPC s'associent pour donner une seconde vie aux matériaux composites
Published on 11/10/2026 at 18:54, 2 hours 37 minutes ago REPLOID Group AG pursues entry in the US market and secures exclusivity to conduct due diligence for the potential acquisition of Chapul, LLC.
Published on 11/10/2026 at 18:45, 2 hours 46 minutes ago Special Optics Introduces Purpose-Built Microscope Objectives for Quantum Applications
Published on 11/10/2026 at 18:00, 3 hours 31 minutes ago Déclaration du nombre total des droits de vote et du nombre d’actions au 31 octobre 2026
Published on 11/10/2026 at 17:45, 3 hours 46 minutes ago Damartex / Descriptif du programme de rachat d'actions
Published on 11/10/2026 at 17:35, 3 hours 56 minutes ago ENGIE - Déclaration du nombre total d'actions et de droits de vote au 31 octobre 2026
Published on 11/10/2026 at 17:31, 4 hours ago CNP Assurances SA annonce le succès de l’émission d’une obligation subordonnée Tier 2 de 500 M€.
